Health Canada has issued a public advisory that some bottles of JAMP Venlafaxine, a popular anti-depressant, are mislabeled, putting users at risk of overdose.
The bottles containing 100 capsules were sold to pharmacies. They may contain 150 mg capsules, which are light brown, instead of the grey and pink 37.5 mg capsules. The capsules have an expiry date of September 2024.
Only mislabeled bottles are being recalled. The agency said it is possible pharmacists did not recognize the error and repackaged the capsules for customers.
Users should check their medication to ensure it is the correct dose and call their pharmacist if they are unsure or have the wrong capsules.
If you experience an allergic reaction, gastrointestinal bleeding, including vomiting blood or blood in stool, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache, call your healthcare provider immediately. A sudden dose increase could also cause chills, high blood pressure, decreased appetite, nausea, agitation, dizziness, sleepiness, yawning, tremor or sweating.
Doctors prescribe Venlafaxine to relieve symptoms of major depressive disorder and anxiety caused by generalized anxiety disorder, social anxiety disorder, and panic disorder.
